Literature DB >> 26474199

Harvoni (ledipasvir and sofosbuvir) for hepatitis C.

Caitlin Mullins1, Whitney Gibson, Olga M Klibanov.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26474199     DOI: 10.1097/01.NPR.0000472253.59198.1c

Source DB:  PubMed          Journal:  Nurse Pract        ISSN: 0361-1817


× No keyword cloud information.
  3 in total

1.  Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C.

Authors:  Sammy Saab; Justin Rheem; Melissa A Jimenez; Tiffany M Fong; Michelle H Mai; Caterina A Kachadoorian; Negin L Esmailzadeh; Sherona N Bau; Susan Kang; Samantha D Ramirez; Jonathan Grotts; Gina Choi; Francisco A Durazo; Mohammed M El-Kabany; Steven-Huy B Han; Ronald W Busuttil
Journal:  J Clin Transl Hepatol       Date:  2017-05-14

2.  Sulforaphane Suppresses Hepatitis C Virus Replication by Up-Regulating Heme Oxygenase-1 Expression through PI3K/Nrf2 Pathway.

Authors:  Jung-Sheng Yu; Wei-Chun Chen; Chin-Kai Tseng; Chun-Kuang Lin; Yao-Chin Hsu; Yen-Hsu Chen; Jin-Ching Lee
Journal:  PLoS One       Date:  2016-03-29       Impact factor: 3.240

3.  A Simple but Accurate Method for Evaluating Drug-Resistance in Infectious HCVcc System.

Authors:  Jian-Rui Li; Wen-Jing Li; Jun-Jun Cheng; Meng-Hao Huang; Zhou-Yi Wu; Chen-Chen Jiang; Hu Li; Jin-Hua Chen; Xiao-Qin Lv; Biao Dong; Jian-Dong Jiang; Zong-Gen Peng
Journal:  Biomed Res Int       Date:  2017-08-22       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.